Research Peptides
RESEARCH USE ONLY
Research Peptides
RESEARCH USE ONLY
| Ingredients | Repair blend peptide (BPC-157 + TB-500) — pentadecapeptide + thymosin beta-4 fragment Ac-LKKTETQ |
|---|---|
| Storage | Refrigerate at 2-8°C, protect from light, do not freeze |
| Shelf life | 24 months |
| SKU | Content - Spec | Pack | Price | Stock |
|---|---|---|---|---|
| BB10 | 10mg | 10 vials | $119.00 | In stock |
| BB20 | 20mg | 10 vials | $159.00 | In stock |
Research reagents are for laboratory and in-vitro research only. Not for human use.
Research reagents are not supplied as medicines and must not be used for diagnosis, treatment, prevention, clinical procedures or self-medication. Product information must not be used as administration or dosing guidance.
For accessories and consumables, follow their own specifications and documented intended use.
BPC-157 & TB-500 Combo (5mg/5mg) is a balanced blend of two highly researched tissue repair peptides. BPC-157, derived from human gastric juice proteins, promotes healing through VEGFR2 upregulation, enhanced nitric oxide synthesis, and cytoprotective effects, while accelerating tendon, ligament, muscle, and gastrointestinal repair. TB-500 (Thymosin Beta-4) enhances cell migration, actin polymerization, angiogenesis, and reduces inflammation, supporting faster wound closure and multi-tissue regeneration. Together, they provide complementary mechanisms for comprehensive musculoskeletal, gastrointestinal, cardiovascular, and neuroprotective recovery. This lower-dose format is ideal for introductory research protocols in post-injury rehabilitation, sports medicine, wound healing, and scar reduction.
Promotes repair of muscle, tendon and ligament tissue; accelerates wound healing; reduces inflammatory response; supports joint health; promotes angiogenesis; enhances overall recovery rate
Once daily at 250-500mcg per dose, administered subcutaneously or intramuscularly; cycle length 4-6 weeks; adjust the specific dosage according to the severity of the injury
Individuals with sports injuries; patients undergoing post-operative rehabilitation; patients with chronic inflammation; older adults with degenerative joint conditions